New shot targets leukemia cells in Tough-to-Treat patients
NCT ID NCT07371533
First seen Jan 29, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This study tests an experimental antibody called A-319 for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not fully cleared after chemotherapy. The treatment is given as a shot under the skin and aims to help the immune system attack cancer cells. The main goals are to check if it is safe and to see how well it works in about 18 people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.